Wegovy Insurance Coverage in Texas 2025: What Patients Need to Know
Getting Wegovy covered in Texas is possible, but it takes preparation. Here's what Houston patients need to know about insurance, prior auth, and appeals.
Reviewed for accuracy against current FDA guidance, peer-reviewed clinical trial data (STEP, SURMOUNT trials), and manufacturer prescribing information. See our editorial standards.
Most Texas insurance plans still don't cover Wegovy — but more are paying for it in 2025 than ever before, and the gap is closing faster than most Houston patients realize. A growing number of Texas employers have added GLP-1 obesity benefits this year, and major carriers have published clearer prior authorization criteria that give physician-supervised clinics a real roadmap for getting claims approved. Patients in Sugar Land, The Woodlands, and Katy are winning approvals that would have been dead on arrival two years ago. This article covers which Texas insurers are covering Wegovy in 2025, what your doctor needs to document, and exactly what to do if you get denied.
1Why Texas Lags Behind on GLP-1 Coverage
Texas has no state mandate requiring commercial insurers to cover obesity medications. That puts it behind states like New York, which passed legislation pushing broader GLP-1 access. In practice, this means your coverage depends almost entirely on what your employer chose to include in their benefits plan. Texas Medicaid, which covers many low-income Houstonians, does not currently cover Wegovy for weight loss. It can cover semaglutide under the brand Ozempic when prescribed for Type 2 diabetes, but that is a different indication with different criteria. Texas state employee health plans through ERS (Employees Retirement System) also excluded Wegovy as of early 2025, though advocates are actively pushing for a policy change. The result is a patchwork. A teacher in Katy ISD and a nurse at Memorial Hermann may have completely different coverage outcomes for the same medication. The first step is always knowing exactly which plan you are on and reading the formulary yourself.
2Which Houston-Area Insurers Are Covering Wegovy in 2025
Coverage varies widely, but here is a realistic picture of the major carriers serving Greater Houston patients. Blue Cross Blue Shield of Texas covers Wegovy on some PPO and HMO plans, but only when the employer has opted into obesity drug coverage. Many large Houston employers along the Energy Corridor have done this. Smaller businesses often have not. Aetna and Cigna both offer employer-sponsored plans that can include GLP-1 coverage, but again, the employer decides. If you work for a major health system or a Fortune 500 company headquartered near the Galleria or Downtown Houston, your odds are better. United Healthcare has been one of the more restrictive large carriers. Some UHC plan members in The Woodlands and Sugar Land have reported approvals, but denials remain common without thorough documentation. Humana covers Wegovy on select plans, particularly Medicare Advantage plans that have added obesity drug riders following the 2024 federal rule allowing Medicare Part D to cover anti-obesity medications. Always call the member services number on your insurance card and ask specifically about Wegovy NDC codes before assuming you are covered.
3The Clinical Data Insurers Want to See
Insurance companies do not approve Wegovy because a patient asks nicely. They approve it when a physician submits documentation that matches the clinical criteria they have written into their policy. The STEP trials, which led to Wegovy's FDA approval in 2021, are the foundation of every coverage argument. STEP 1 showed that adults with obesity who used semaglutide 2.4 mg weekly lost an average of 14.9 percent of their body weight over 68 weeks, compared to 2.4 percent with placebo. That is hard data your doctor can cite directly in a prior authorization letter. SEP 5 extended those findings to patients with Type 2 diabetes, showing 9.6 percent mean weight loss. And the SELECT trial, published in 2023, showed semaglutide reduced major cardiovascular events by 20 percent in adults with obesity and established cardiovascular disease. That finding has opened doors with some carriers who previously refused coverage. If your doctor submits a prior auth letter that references these trials and connects them to your specific diagnoses, BMI, and comorbidities, the request looks very different from a generic form submission.
4Prior Authorization: What Your Doctor Needs to Document
Most insurers require a prior authorization (PA) before they will fill Wegovy. This is not optional and missing documentation is the most common reason first requests fail. Here is what a solid PA submission typically includes. Your BMI must meet the threshold, usually 30 or above, or 27 or above with at least one weight-related comorbidity like hypertension, sleep apnea, or high cholesterol. Your doctor needs to document that number in your chart with a date. Comorbidities matter enormously. If you have been diagnosed with prediabetes, fatty liver disease, or obstructive sleep apnea, those diagnoses need to be active and coded correctly. A clinic near the Texas Medical Center that sees obesity regularly will know which ICD-10 codes to use. Insurers also want evidence of a prior weight loss attempt. This usually means documentation of a structured diet program, a behavioral program, or a period of physician-supervised lifestyle intervention. It does not always have to be formal, but it needs to be in your chart. Finally, the letter itself should state the clinical rationale clearly. A one-paragraph form letter rarely gets approved on the first try. A detailed letter that quotes the STEP 1 data and maps it to your patient profile stands a much better chance.
5What to Do When You Get a Denial
A denial is not the end. Most first-time PA requests for Wegovy get denied, and many of those are reversed on appeal. When you receive a denial letter, read it carefully. Insurers are required to give a specific reason. The most common reasons are: the plan does not cover anti-obesity medications, the documentation does not show a prior failed attempt, or the patient does not meet BMI criteria as documented. For each of these, there is a response. If the plan exclusion is the issue, request a copy of your plan documents and look for any exception language related to medically necessary obesity treatment. Your HR department can help. If documentation is the issue, ask your doctor to write a more detailed appeal letter. Clinics with dedicated insurance coordinators, which you can find in Houston communities like Pearland, Cypress, and Friendswood, are experienced at this. You have the right to an external review if your internal appeal fails. In Texas, the Texas Department of Insurance (TDI) oversees this process. File at tdi.texas.gov. An independent reviewer looks at the denial without any relationship to your insurer. Approval rates at this stage are lower, but it costs you nothing to try.
6Medicare, Medicaid, and Marketplace Plans in Texas
These three programs each work differently and each has its own Wegovy story in 2025. Medicare Part D: The Inflation Reduction Act of 2022 allowed Medicare to negotiate drug prices, and a 2024 rule change allowed Part D plans to cover anti-obesity medications starting in 2026. In 2025, some Medicare Advantage plans voluntarily added coverage. If you are a Medicare patient in Houston, call your plan and ask specifically whether Wegovy is on your 2025 formulary. Plans in the Houston metro area from Humana and UHC have varied widely. Texas Medicaid: As noted above, Wegovy is not covered for weight loss under Texas Medicaid. If you have Type 2 diabetes and a doctor willing to prescribe Ozempic for that indication, that is a separate pathway worth discussing with your physician. Marketplace Plans (ACA): Plans sold on healthcare.gov in Texas vary by metal tier and insurer. Bronze plans rarely cover Wegovy. Some Gold and Platinum plans from BCBS and Ambetter do, but it depends on the specific plan year and formulary. Check the formulary PDF before you enroll, not after.
7Manufacturer Savings and Backup Options If Insurance Fails
If insurance will not cover Wegovy, you are not automatically stuck paying $1,350 a month. Novo Nordisk runs the Wegovy WeightLoss.com savings program. Commercially insured patients who qualify may pay as little as $0 for the first month and $25 per month after that, depending on their plan. This program does not work for Medicare or Medicaid patients. Novo Nordisk also has a patient assistance program for uninsured or underinsured patients below certain income thresholds. Your doctor's office or a clinic in Humble, Stafford, or League City that handles a lot of GLP-1 prescriptions will know how to submit that application. Compounded semaglutide has been widely available during the FDA shortage period, but the FDA removed semaglutide from the shortage list in early 2025. Compounded versions are not FDA-approved. Patients should understand that compounded products have not undergone the same safety and efficacy review as Wegovy. Discuss this with your doctor. Tirzepatide under the brand Zepbound may have different coverage on your plan than Wegovy. Always ask your doctor and insurer about both options, because formulary placement is not always logical.
8How to Choose a Houston Clinic That Knows the Insurance Process
The physician who prescribes Wegovy matters as much as the drug itself. A clinic that handles insurance authorization regularly will have staff dedicated to PA submissions and appeals. That process is labor-intensive and many primary care offices simply do not have the bandwidth. Look for obesity medicine physicians who are board-certified through the American Board of Obesity Medicine (ABOM). These providers understand the clinical criteria insurers use because they helped write the treatment guidelines. Ask any clinic you contact these direct questions: Do you handle prior authorization in-house? Do you have someone on staff who manages insurance appeals? Have you successfully appealed Wegovy denials with my specific carrier? Clinics along the 59/69 corridor in Southwest Houston, near I-10 in Katy, and around FM 1960 in North Houston have grown their GLP-1 programs significantly in the past two years. Patient volume at these clinics means their staff has seen most insurer quirks before and knows how to respond. A clinic that cannot answer those questions confidently may leave you doing the insurance work yourself. That is a significant burden when you are also managing a chronic condition.
Wegovy coverage in Texas in 2025 is real, but it rarely happens automatically. It takes the right documentation, the right physician, and sometimes a fight through the appeals process. The good news is that Houston has clinics built specifically to handle this. Use the Houston Weight Loss Directory to find an obesity medicine provider near you who knows how to get this done.
Sources & References
Clinical data referenced in this article is drawn from the FDA drug database, peer-reviewed publications (STEP trials, SURMOUNT trials), and manufacturer prescribing information for Wegovy, Ozempic, Zepbound, and Mounjaro. Pricing figures reflect publicly available estimates and may vary. Insurance coverage information is general guidance — confirm your specific benefits with your plan.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed physician before starting any weight loss medication or program.